Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation.
Francesca OrzanFrancesca De BaccoElisabetta LazzariniGiovanni CrisafulliAlessandra GaspariniAngelo DipasqualeLudovic BaraultMarco MacagnoPasquale PersicoFederico PessinaBeatrice Claudia BonoLaura GiordanoPietro ZeppaAntonio MelcarnePaola CassoniDiego GarbossaArmando SantoroPaolo Maria ComoglioStefano IndraccoloMatteo SimonelliCarla BoccaccioPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
This study shows potentialities and limitations of CSF liquid biopsy in achieving molecular characterization of gliomas at first clinical presentation and proposes a protocol to maximize diagnostic information retrievable from CSF DNA.